Ftse Mib
33.770,05
0,07%
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.103,53
1,49%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Atara Biotherapeutics Inc (ATRA) Atara Biotherapeutics Inc (ATRA) Notizie

Atara Biotherapeutics Inc

ATRA
0,64
-0,0445 (-6,50%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:12:51
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/4/202422:01BWAtara Biotherapeutics, Inc. Reports Inducement Grant Under..
28/3/202413:30BWAtara Biotherapeutics Announces Fourth Quarter and Full Year..
07/3/202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202402:21EDGAR2Form 144 - Report of proposed sale of securities
05/3/202402:19EDGAR2Form 144 - Report of proposed sale of securities
05/3/202402:18EDGAR2Form 144 - Report of proposed sale of securities
05/3/202402:17EDGAR2Form 144 - Report of proposed sale of securities
29/2/202415:05BWAtara Biotherapeutics Receives FDA Clearance of IND..
28/2/202422:30BWAtara Biotherapeutics to Participate in Cell Therapy Panel..
23/2/202422:30EDGAR2Form 8-K - Current report
14/2/202415:00BWAtara Biotherapeutics Announces Submission of..
01/2/202408:25PRNUSAtara Biotherapeutics and Pierre Fabre Laboratories Announce..
01/2/202400:30BWAtara Biotherapeutics and Pierre Fabre Laboratories Announce..
09/1/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/1/202422:01EDGAR2Form 8-K - Current report
08/1/202415:00BWAtara Biotherapeutics Announces $15 Million Registered..
08/1/202414:11EDGAR2Form 8-K - Current report
08/1/202414:00BWAtara Biotherapeutics to Present Recent Progress and Key..
04/1/202422:01BWAtara Biotherapeutics to Present at the 42nd Annual J.P...
03/1/202422:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
20/12/202322:30EDGAR2Form 8-K - Current report
20/12/202322:01BWAtara Biotherapeutics Announces Closing of Expanded Global..
11/12/202318:00BWAtara Biotherapeutics Presents Positive Preclinical Data on..
01/12/202322:01BWAtara Biotherapeutics, Inc. Reports Inducement Grants Under..
30/11/202300:05BWAtara Biotherapeutics To Present Positive New Tab-cel®..
22/11/202322:01BWAtara Biotherapeutics to Participate at the 6th Annual..
20/11/202323:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202323:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202323:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202323:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202322:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
10/11/202322:01BWAtara Biotherapeutics To Participate at the Stifel..
08/11/202323:35BWAtara Biotherapeutics Announces Primary Analysis Data from..
01/11/202322:25EDGAR2Form S-3 - Registration statement under Securities Act of..
01/11/202321:05EDGAR2Form 8-K - Current report
01/11/202313:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202313:35EDGAR2Form 8-K - Current report
01/11/202313:30BWAtara Biotherapeutics Announces Expanded Global Tab-cel®..
06/10/202322:01BWAtara Biotherapeutics, Inc. Reports Inducement Grants Under..
19/9/202322:50DJNAtara Biotherapeutics to Submit New FDA Biologics License..
19/9/202322:01BWAtara Biotherapeutics Announces Plans to Submit Tab-cel® BLA..
Apertura: 0,70 Min: 0,61 Max: 0,7062
Chiusura: 0,6845

La tua Cronologia

NASDAQ
ATRA
Atara Biotherapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network